Escitalopram reduces the risk of depression in patients with HCV treated with interferon alpha


Pre-emptive therapy with the selective serotonin reuptake inhibitor escitalopram in patients initiating interferon therapy for hepatitis C virus (HCV) without psychiatric risk factors reduced the risk of depression, according to a recent study published in the Annals of Internal Medicine.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.